OmniAb (OABI) Cash & Current Investments (2021 - 2026)

OmniAb's (OABI) quarterly Cash & Current Investments came in at $49.1 million in Q1 2026, up 12.56% year-on-year from $43.6 million in Q1 2025, and up 1.01% on a QoQ basis from $48.6 million in Q4 2025.

OmniAb (OABI) Cash & Current Investments (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Cash & Current Investments data on file, last reported at $49.1 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 12.56% year-over-year to $49.1 million in Q1 2026; TTM through Mar 2026 was $49.1 million, a 12.56% increase from a year earlier, with the FY2025 full-year figure at $48.6 million, down 18.26% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $49.1 million, up from $48.6 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for OABI reached as high as $113.6 million in Q1 2023 and fell as low as $19847.0 in Q3 2022.
  • Historically, Cash & Current Investments has averaged $57.5 million across 5 years, with a median of $59.4 million in 2024.
  • Across the five-year window, Cash & Current Investments slumped 94.52% in 2022 and soared 486764.51% in 2023, its largest moves.
  • Year by year, Cash & Current Investments stood at $88.3 million in 2022, then fell by 1.45% to $87.0 million in 2023, then tumbled by 31.67% to $59.4 million in 2024, then decreased by 18.26% to $48.6 million in 2025, then advanced by 1.01% to $49.1 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $49.1 million in Q1 2026, $48.6 million in Q4 2025, and $59.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 OmniAb 260.98 Mn 211.91 Mn 14.41 Mn 49.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 49.07 Mn
Dec 31, 2025 48.58 Mn
Sep 30, 2025 59.50 Mn
Jun 30, 2025 41.62 Mn
Mar 31, 2025 43.60 Mn
Dec 31, 2024 59.43 Mn
Sep 30, 2024 59.38 Mn
Jun 30, 2024 57.23 Mn
Mar 31, 2024 69.01 Mn
Dec 31, 2023 86.98 Mn
Sep 30, 2023 96.63 Mn
Jun 30, 2023 103.15 Mn
Mar 31, 2023 113.61 Mn
Dec 31, 2022 88.27 Mn
Sep 30, 2022 19,847.00
Jun 30, 2022 159,194.00
Mar 31, 2022 434,629.00
Sep 30, 2021 362,203.00
Jun 30, 2021 36,145.00